gene 619 words KG: ELOVL5 2026-03-24
kind:genesection:genesstate:published
Contents

ELOVL5 - Fatty Acid Elongase 5

🧬 Gene Info
Gene SymbolELOVL5
Full NameElongation of Very Long Chain Fatty Acids 5
AliasesPage for ELOVL5
Protein TypeEnzyme
FunctionELOVL5 (Elongation of Very Long Chain Fatty Acids 5) is an endoplasmic reticulum membrane-bound enzyme that catalyzes the rate-limiting step in the elongation of polyunsaturated fatty acids (PUFAs).
Primary Expressionmultiple tissues with brain-relevant localization: - Brain: Cerebellum (Purkinje cells), hippocampus, [cortex](/brai
UniProt ID[Q9NYP7](https://www.uniprot.org/uniprot/Q9NYP7)
Ensembl IDENSG00000012660
GeneCardsELOVL5
Human Protein AtlasELOVL5
BrainCerebellum (Purkinje cells), hippocampus, cortex
RetinaPhotoreceptor cells and retinal pigment epithelium
LiverMajor site of fatty acid elongation
TestisHigh expression for sperm membrane synthesis
Associated Diseasesneurodegeneration
DatabasesGeneCardsNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (2)

Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
Oligodendrocyte White Matter Vulnerability
Score: 0.40

Related Analyses (2)

Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived

Related Experiments (12)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40

See Also (1)

Neurodegeneration
disease · KG edge: implicated_in